作为克隆内异质性对多发性骨髓瘤进展和治疗耐药性影响标志物的血清游离轻链评估

January 1st 2014 • Brioli A, Giles H, Pawlyn C, Campbell J, Kaiser M, Melchor L et al. • Blood 2014;123:3414-9 PMID:24733348